SlateStone Wealth’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.9M Buy
74,534
+2,815
+4% +$656K 1.45% 15
2026
Q1
$17.5M Buy
71,719
+2,223
+3% +$518K 1.45% 16
2025
Q4
$14.4M Buy
69,496
+860
+1% +$170K 1.2% 19
2025
Q3
$12.7M Buy
68,636
+6
+0% +$1.03K 1.1% 24
2025
Q2
$10.5M Sell
68,630
-1,427
-2% -$219K 0.98% 30
2025
Q1
$11.6M Buy
70,057
+193
+0.3% +$30.2K 1.17% 26
2024
Q4
$10.1M Buy
69,864
+1,637
+2% +$254K 0.99% 30
2024
Q3
$11.1M Buy
68,227
+20,458
+43% +$3.26M 1% 29
2024
Q2
$6.98M Sell
47,769
-15,610
-25% -$2.32M 0.76% 38
2024
Q1
$10M Buy
63,379
+24,660
+64% +$3.93M 1.01% 26
2023
Q4
$6.07M Buy
38,719
+1,831
+5% +$281K 0.79% 33
2023
Q3
$5.75M Buy
36,888
+24,461
+197% +$4.04M 0.84% 33
2023
Q2
$2.06M Sell
12,427
-117
-0.9% -$18.9K 0.39% 57
2023
Q1
$1.94M Sell
12,544
-11,001
-47% -$1.78M 0.4% 55
2022
Q4
$4.16M Sell
23,545
-1,763
-7% -$304K 1% 23
2022
Q3
$4.13M Buy
25,308
+1,281
+5% +$217K 1.1% 19
2022
Q2
$4.26M Buy
24,027
+1,284
+6% +$229K 1.09% 19
2022
Q1
$4.03M Buy
22,743
+14,142
+164% +$2.41M 0.9% 23
2021
Q4
$1.47M Sell
8,601
-349
-4% -$57.1K 0.31% 69
2021
Q3
$1.45M Sell
8,950
-1,026
-10% -$175K 0.33% 71
2021
Q2
$1.64M Sell
9,976
-3,473
-26% -$575K 0.38% 65
2021
Q1
$2.21M Sell
13,449
-229
-2% -$37.1K 0.55% 48
2020
Q4
$2.15M Sell
13,678
-10,079
-42% -$1.49M 0.54% 53
2020
Q3
$3.54M Buy
23,757
+2,490
+12% +$368K 0.76% 42
2020
Q2
$2.99M Buy
21,267
+750
+4% +$109K 0.67% 43
2020
Q1
$2.69M Sell
20,517
-1,424
-6% -$202K 0.77% 38
2019
Q4
$3.2M Sell
21,941
-506
-2% -$68.6K 0.73% 39
2019
Q3
$2.9M Sell
22,447
-20,913
-48% -$2.76M 0.85% 32
2019
Q2
$6.04M Sell
43,360
-109
-0.3% -$15.1K 1.7% 14
2019
Q1
$6.08M Buy
43,469
+11,130
+34% +$1.49M 1.87% 12
2018
Q4
$4.17M Buy
+32,339
New +$4.51M 1.92% 12

Other funds holding JNJ

SlateStone Wealth's JNJ Position: Q2 2026 in Review

SlateStone Wealth increased its Johnson & Johnson (JNJ) stake by 3.9% in Q2 2026, buying an estimated $656K and bringing the position to 74,534 shares worth $18.9M. The position accounts for 1.45% of the portfolio, ranked #15.

SlateStone Wealth first reported a position in JNJ in Q4 2018 and has held it in 31 quarters since. 2,122 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • SlateStone Wealth held 74,534 shares of Johnson & Johnson worth $18.9M as of Q2 2026.
  • SlateStone Wealth bought 2,815 Johnson & Johnson shares in Q2 2026, an estimated $656K.
  • Johnson & Johnson made up 1.45% of SlateStone Wealth's portfolio in Q2 2026, its #15 holding.
  • SlateStone Wealth first reported a position in Johnson & Johnson in Q4 2018 and has held it in 31 quarters since.
  • 2,122 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on SlateStone Wealth's 13F filing for Q2 2026, filed 20 Jul 2026.